AbCellera to Report Third Quarter 2024 Financial Results on November 4, 2024
September 26 2024 - 4:05PM
Business Wire
AbCellera (Nasdaq: ABCL) will announce its third quarter 2024
financial results on Monday, November 4, 2024, and hold an earnings
conference call at 2:00 p.m. Pacific Time (5:00 p.m. Eastern Time)
the same day.
A live audio webcast of the earnings conference may be accessed
through a link that will be posted on AbCellera’s Investor
Relations website. A replay will be available through the same link
following the conference call.
About AbCellera Biologics Inc.
AbCellera (Nasdaq: ABCL) discovers and develops antibody
medicines for indications across therapeutic areas including
cancer, metabolic and endocrine conditions, and autoimmune
disorders. AbCellera’s engine integrates technology, data science,
infrastructure, and interdisciplinary teams to solve the most
challenging antibody discovery problems. AbCellera is focused on
advancing an internal pipeline of first-in-class and best-in-class
programs and collaborating on innovative drug development programs
with partners. For more information, please visit
www.abcellera.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240926882302/en/
Inquiries Media: Kathleen Reid; media@abcellera.com,
+1(236)521-6774 Business Development: Murray McCutcheon, Ph.D.;
bd@abcellera.com, +1(604)559-9005 Investor Relations: Melanie
Solomon; ir@abcellera.com, +1(778)729-9116
AbCellera Biologics (NASDAQ:ABCL)
Historical Stock Chart
From Oct 2024 to Nov 2024
AbCellera Biologics (NASDAQ:ABCL)
Historical Stock Chart
From Nov 2023 to Nov 2024